Webinar Details
This promotional webinar is organised and funded by Daiichi Sankyo UK and is for Healthcare Professionals and Allied Healthcare Professionals in the UK only.
How to Manage the Cardiovascular Risk of the Patient Sat in Front of You
Thursday 21st November 13.00-14.00
Key Takeaways
- Understanding why preventing CVD in Primary Care is important
- Understanding how to risk stratify patients and management of modifiable risk factors
- Hints and tips of how to improve patient consultations, including challenging patients' beliefs around managing risk factors
Chair
Sue Alldred, PCPA Regional VP for the NE, Clinical Head of Pharmacy, South and East Leeds General Practice Group
Guest Speaker
Alia Gilani, Senior Diabetes Clinical Pharmacist
Speaker
Alia Gilani
Alia is a Senior Diabetes Clinical Pharmacist whose interests lie in ethnic inequalities and diabetes. She helped established and run a bi-lingual medication review service in NHS Glasgow in 2002. This was the “MELT” service (Minority Ethnic Long Term medicines Service).
She is involved in healthcare professional’s education by delivering lectures both locally and nationally on topics ranging from, managing diabetes during Ramadan to tackling health and ethnic inequalities. She is on the editorial board of Diabetes in Primary Care Journal and contributes to several journals by writing articles on diabetes related topics.
Alia currently works freelance for the NHS and for companies delivering education around the UK to healthcare professionals.
About Daiichi Sankyo UK
Count on us to keep them in the moment. At Daiichi Sankyo UK, we create and supply innovative products to help the NHS to deliver better patient care in the fields of cardiovascular disease and oncology.
Our mission is to contribute to the enrichment of quality of life through the discovery and delivery of innovative medicines that address diverse and unmet medical needs.
For more information visit https://www.daiichi-sankyo.co.uk
Job code: UK/CVD/10/24/0006 with a date of preparation of October 2024.